Revexepride

DB20324InvestigationalSmall molecule

Revexepride is a small molecule drug. The usage of the INN stem '-pride' in the name indicates that Revexepride is a sulpiride derivative and analogue. Revexepride is under investigation in... Revexepride is under investigation in clinical trial NCT01472939 (Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)).

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 4
Curator reviewed
Formula / weight: C₂₁H₃₂ClN₃O₄ · 425.95 g/mol (avg)
Code names: M0003 · M-003 · R-149402 · SPD-557

Resolves to

Compound

UNII8C63R2Y02MCAS219984-49-3ChEMBLCHEMBL3545035ChEBI755426PubChem9823762

Structure

InChIKeyFOUUNSGQVBGYQM-SUMWQHHRSA-NSMILESCOCCCN1CC[C@@H](CNC(=O)C2=CC(Cl)=C(N)C3=C2OC(C)(C)C3)[C@H](O)C1

Targets

Q13639HTR4

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Revexepride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account